[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB0812309D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB0812309D0
GB0812309D0 GBGB0812309.3A GB0812309A GB0812309D0 GB 0812309 D0 GB0812309 D0 GB 0812309D0 GB 0812309 A GB0812309 A GB 0812309A GB 0812309 D0 GB0812309 D0 GB 0812309D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0812309.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma SA
Original Assignee
UCB Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Pharma SA filed Critical UCB Pharma SA
Priority to GBGB0812309.3A priority Critical patent/GB0812309D0/en
Publication of GB0812309D0 publication Critical patent/GB0812309D0/en
Priority to PCT/GB2009/001659 priority patent/WO2010001126A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0812309.3A 2008-07-03 2008-07-03 Therapeutic agents Ceased GB0812309D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0812309.3A GB0812309D0 (en) 2008-07-03 2008-07-03 Therapeutic agents
PCT/GB2009/001659 WO2010001126A1 (en) 2008-07-03 2009-07-02 Thiophene derivatives as kinase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0812309.3A GB0812309D0 (en) 2008-07-03 2008-07-03 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB0812309D0 true GB0812309D0 (en) 2008-08-13

Family

ID=39718014

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0812309.3A Ceased GB0812309D0 (en) 2008-07-03 2008-07-03 Therapeutic agents

Country Status (2)

Country Link
GB (1) GB0812309D0 (en)
WO (1) WO2010001126A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009094224A1 (en) 2008-01-25 2009-07-30 Millennium Pharmaceuticals, Inc. Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors
US9090601B2 (en) 2009-01-30 2015-07-28 Millennium Pharmaceuticals, Inc. Thiazole derivatives
JP2012516329A (en) 2009-01-30 2012-07-19 ミレニアム ファーマシューティカルズ, インコーポレイテッド Heteroaryls and their use as PI3K inhibitors
US8796314B2 (en) 2009-01-30 2014-08-05 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
AR082665A1 (en) 2010-08-11 2012-12-26 Millennium Pharm Inc INHIBITING HETEROARILIC DERIVATIVES OF PI3K KINASES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE OF THE SAME TO TREAT PROLIFERATIVE, INFLAMMATORY AND / OR CARDIOVASCULAR DISORDERS
JP2013533318A (en) 2010-08-11 2013-08-22 ミレニアム ファーマシューティカルズ, インコーポレイテッド Heteroaryl and uses thereof
US9062038B2 (en) 2010-08-11 2015-06-23 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
SG189396A1 (en) 2010-10-13 2013-05-31 Millennium Pharm Inc Heteroaryls and uses thereof
US9278958B2 (en) * 2012-06-22 2016-03-08 Katholieke Universiteit Leuven K.U. Leuven R&D Anti-cancer compounds
CN110759900B (en) * 2019-10-25 2021-07-30 沈阳药科大学 Preparation method and application of thiophene compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0611152D0 (en) * 2006-06-06 2006-07-19 Ucb Sa Therapeutic agents

Also Published As

Publication number Publication date
WO2010001126A1 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
GB0811304D0 (en) Therapeutic agents
EP2117311A4 (en) Therapeutic agents
GB0811643D0 (en) New therapeutic agents
GB0908957D0 (en) Therapeutic agents
GB0819593D0 (en) Therapeutic agents
HRP20130041T8 (en) Therapeutic agents
GB0821693D0 (en) Therapeutic agents
GB0723747D0 (en) Therapeutic agents
GB0812309D0 (en) Therapeutic agents
GB0805818D0 (en) Therapeutic agents
GB0801081D0 (en) Therapeutic agents
GB0801080D0 (en) Therapeutic agents
GB0724340D0 (en) Novel Therapeutic Agents
EP2454276A4 (en) Therapeutic agents
GB0723748D0 (en) Therapeutic agents
GB0811715D0 (en) Therapeutic agents
GB0910493D0 (en) Therapeutic agents
GB0812558D0 (en) Therapeutic agents
GB0801082D0 (en) Therapeutic agents
GB0815177D0 (en) Therapeutic agents
GB0812563D0 (en) Therapeutic agents
GB0820275D0 (en) Therapeutic agents
GB0815765D0 (en) New therapeutic agents
GB0723751D0 (en) Therapeutic agents
GB0723749D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)